[
  {
    "ts": "2025-10-01T23:51:51+00:00",
    "headline": "Canaccord Genuity Raises Price Target on Insulet Corporation (PODD) to $399, Maintains Buy Rating",
    "summary": "With significant upside potential, Insulet Corporation (NASDAQ:PODD) secures a spot on our list of the 13 Best Quality Stocks to Buy According to Hedge Funds. On September 29, given Insulet Corporation (NASDAQ:PODD)’s dominant position in the insulin pump industry and its first-mover advantage in the type 2 diabetes market, Canaccord Genuity increased its price objective […]",
    "url": "https://finance.yahoo.com/news/canaccord-genuity-raises-price-target-235151989.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "88fcd43f-5024-3b6a-91f3-4f415ab54ed4",
      "content": {
        "id": "88fcd43f-5024-3b6a-91f3-4f415ab54ed4",
        "contentType": "STORY",
        "title": "Canaccord Genuity Raises Price Target on Insulet Corporation (PODD) to $399, Maintains Buy Rating",
        "description": "",
        "summary": "With significant upside potential, Insulet Corporation (NASDAQ:PODD) secures a spot on our list of the 13 Best Quality Stocks to Buy According to Hedge Funds. On September 29, given Insulet Corporation (NASDAQ:PODD)’s dominant position in the insulin pump industry and its first-mover advantage in the type 2 diabetes market, Canaccord Genuity increased its price objective […]",
        "pubDate": "2025-10-01T23:51:51Z",
        "displayTime": "2025-10-01T23:51:51Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/220d544dda042826f0ea41b0492099ed",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Canaccord Genuity Raises Price Target on Insulet Corporation (PODD) to $399, Maintains Buy Rating",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CPLfnRzslE8EKK7Co2CbUw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/220d544dda042826f0ea41b0492099ed.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1GFptbZE3fjYLFCNJ_SINg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/220d544dda042826f0ea41b0492099ed.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/canaccord-genuity-raises-price-target-235151989.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/canaccord-genuity-raises-price-target-235151989.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PODD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-01T17:56:28+00:00",
    "headline": "Insulet Corporation (PODD) Q2 Revenue Surges 32.9% to $649M, Raises Full-Year Guidance",
    "summary": "We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. Insulet Corporation is one of them. Insulet Corporation (NASDAQ:PODD) is a global leader in tubeless insulin pump technology, offering innovative diabetes management solutions through its Omnipod Insulin Management System. The flagship Omnipod 5 Automated Insulin Delivery System […]",
    "url": "https://finance.yahoo.com/news/insulet-corporation-podd-q2-revenue-175628805.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "f442e2c4-2da1-36c6-b535-1b53b39c818e",
      "content": {
        "id": "f442e2c4-2da1-36c6-b535-1b53b39c818e",
        "contentType": "STORY",
        "title": "Insulet Corporation (PODD) Q2 Revenue Surges 32.9% to $649M, Raises Full-Year Guidance",
        "description": "",
        "summary": "We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. Insulet Corporation is one of them. Insulet Corporation (NASDAQ:PODD) is a global leader in tubeless insulin pump technology, offering innovative diabetes management solutions through its Omnipod Insulin Management System. The flagship Omnipod 5 Automated Insulin Delivery System […]",
        "pubDate": "2025-10-01T17:56:28Z",
        "displayTime": "2025-10-01T17:56:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/066fc7bbc0e30e3f919eb17b3f120c9e",
          "originalWidth": 1920,
          "originalHeight": 1365,
          "caption": "Insulet Corporation (PODD) Q2 Revenue Surges 32.9% to $649M, Raises Full-Year Guidance",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/omawnvNHL2Yv3Eh5TrgBiQ--~B/aD0xMzY1O3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/066fc7bbc0e30e3f919eb17b3f120c9e.cf.webp",
              "width": 1920,
              "height": 1365,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/za7rHrbMnojnDORHK32_hg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/066fc7bbc0e30e3f919eb17b3f120c9e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/insulet-corporation-podd-q2-revenue-175628805.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/insulet-corporation-podd-q2-revenue-175628805.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PODD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]